[{"AccountsPayableCurrent_0_Q3_USD":2392000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1082000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1683000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":25000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":2000.0,"OtherNonoperatingIncome_3_Q3_USD":25000.0,"OtherNonoperatingIncome_1_Q3_USD":2000.0,"OtherAssetsNoncurrent_0_Q3_USD":6133000.0,"OtherAssetsCurrent_0_Q3_USD":91486000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1280000.0,"OperatingIncomeLoss_3_Q3_USD":-18677000.0,"OperatingIncomeLoss_1_Q3_USD":-7374000.0,"OperatingExpenses_3_Q3_USD":18677000.0,"OperatingExpenses_1_Q3_USD":7374000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-18652000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-7372000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-18652000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-7372000.0,"NetIncomeLoss_3_Q3_USD":-18652000.0,"NetIncomeLoss_1_Q3_USD":-7372000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1395000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-17279000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":4996000.0,"RestrictedCash_0_Q3_USD":400000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":997949.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":1428054.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":25475905.0,"TemporaryEquitySharesIssued_0_Q3_shares":25475905.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":33701081.0,"TemporaryEquityLiquidationPreference_0_Q3_USD":122237000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":141181000.0,"StockholdersEquityNoteStockSplitConversionRatio1_0_Q3_pure":1.3229,"StockholdersEquity_0_Q3_USD":-50145000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4699003.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0103,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.7614,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.8356,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":915476.0,"ShareBasedCompensation_3_Q3_USD":2777000.0,"SecurityDeposit_0_Q3_USD":400000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-52922000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":378000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":13306000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1428054.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":99604000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":97619000.0,"Depreciation_3_Q3_USD":1000.0,"DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense_3_Q3_USD":2777000.0,"DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense_1_Q3_USD":1293000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-18652000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-7372000.0,"CommonStockSharesOutstanding_0_Q3_shares":2054555.0,"CommonStockSharesIssued_0_Q3_shares":2054555.0,"CommonStockSharesAuthorized_0_Q3_shares":41083993.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":31090384.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":82325000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":90782000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":90404000.0,"Assets_0_Q3_USD":97619000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":31090384.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1293000.0,"AdditionalPaidInCapital_0_Q3_USD":2777000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":112000.0,"DividendsCommonStockCash_3_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":5680000.0,"EarningsPerShareBasic_1_Q3_USD":-5.16,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-5.16,"Liabilities_0_Q3_USD":6583000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":757000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":780000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":803000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":827000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":2635000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":5802000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":969000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":2640000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1367000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":837000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":5371000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2378000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-18.69,"EarningsPerShareBasic_3_Q3_USD":-18.69,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":997949.0,"Ticker":"THRX","CIK":"1745020","name":"THESEUS PHARMACEUTICALS, INC.","OfficialName":"Theseus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"450111820.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]